Here's what I don't get. How does a random (in the public's eyes, obviously we think we know what we have) pre-revenue biotech OTC which hasn't had a PR in over 2 months trade over 2 million shares daily volume without a fundamental or technical catalyst? I've been watching OTCs for years and really the only OTC tickers I can think of that constantly trade CYDY-like volume are FNMA and FNMC, but they're massive companies sponsored by the federal government with big revenues. We've had a couple days recently where we were under a million in volume, but other than that we trade at least a million shares a day - even with no recent news. From my experience that's very abnormal for any OTC, let alone a pre-rev biotech. Closest I can think of is NWBO, but they have quite a few days with volume under 1 million.

If I said I knew what to extrapolate from it, I'd be lying. Interesting to me, but I don't have any idea what it means. Someone is accumulating shares from retail traders who tap out for whatever reason? I don't know.